ClinicalTrials.gg
Not yet recruitingNCT07271524Updated Dec 9, 2025

Non-invasive Deep Brain Stimulation to Improve Spatial Navigation Abilities in Individuals Following Traumatic Brain Injury

An interventional study of Transcranial electric stimulation in Traumatic Brain Injury, sponsored by Friedhelm Hummel. Not yet recruiting at 2 sites in Switzerland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-12-09.

Sponsored by Friedhelm Hummel · Not applicable, Interventional, and Basic science

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
25
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 31 studies in Brain Injuries, Traumatic with a site in Switzerland — 6 open to participants now, 8 under way, 2 of them phase 3. Brain Injuries, Traumatic · Switzerland.

Planned enrollment
12th of 23
25 · median 25
Started
2025
with 2 others
No phase
18 of 31
5 open now
Registered
28th of 31
by date
Lead sponsor
2 of 31
Friedhelm Hummel

Among the 31 studies in Brain Injuries, Traumatic with a site in Switzerland, this one is the 12th largest by planned enrollment of the 23 interventional ones that give a count, is one of 3 that started in 2025, is one of 18 with no phase, and was the 28th registered.

Brain Injuries, Traumatic

1,725 studies on the registry are indexed under Brain Injuries, Traumatic; 450 are open to participants now.

Browse Brain Injuries, Traumatic studies →

Open to participants now

6 of the 31 studies in Brain Injuries, Traumatic with a site in Switzerland are open now. Recruiting first, the newest first:

All 6 open studies →

A study can be open while its sites in Switzerland have not opened yet or have stopped. Only those recruiting at a site in Switzerland →

Who these studies take

Of the 287 Brain Injuries, Traumatic studies recruiting now, 126 (44%) set no upper age limit and 119 (41%) stop at 75 or younger; 41 take children under 18; 53 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 31 studies in Brain Injuries, Traumatic with a site in Switzerland, or all of them as a file.
02

Study summary

Impairments in spatial memory and spatial navigation are commonly reported amongst patients presenting post-traumatic brain injury (TBI). In this study, the investigators examine the effect of non-invasive deep brain stimulation of the hippocampal-entorhinal complex (HC-EC), a key region supporting navigation abilities, on spatial navigation performance in TBI patients. Using a virtual reality task where participants must first encode and later recall the location of objects in a virtual arena, the investigators contrast performance while active versus control stimulation is applied to the HC-EC. The investigators additionally record brain activity using electroencephalography (EEG) prior to, during, and after task performance to characterize the neural correlates of spatial navigation abilities in TBI patients, and how they are affected by stimulation.

Read the detailed description

Patients will perform a virtual reality spatial navigation task comparable to that used previously by Beanato and colleagues (2024; DOI: 10.1126/sciadv.ado4103). Patients will perform 4 blocks of task, each lasting approximately 10 minutes; during the full duration of each block, either active or control transcranial temporal interference stimulation (tTIS) will be applied in an interleaved manner, and EEG recordings will be collected. Resting-state EEG recordings will also be collected prior to and following task performance.

Structural, diffusion-weighted, and resting-state MRI scans will additionally be performed during a prior baseline session.

03

Conditions studied

  • Traumatic Brain Injury

Keywords

  • non-invasive brain stimulation
  • deep brain stimulation
  • subcortical
  • memory
  • neuro-imaging
  • transcranial temporal interference stimulation
  • spatial navigation
  • electroencephalography
  • traumatic brain injury
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥ 18 years
  • Clinical diagnosis of TBI
  • No history of other severe neurological or psychiatric disorders

Exclusion criteria

Exclusion Criteria:

  • Unable to consent
  • Severe neuropsychiatric (e.g., major depression, severe dementia) or unstable systemic diseases (e.g., severe progressive and unstable cancer, life threatening infectious diseases)
  • Severe sensory or cognitive impairment or musculoskeletal dysfunctions prohibiting to understand instructions or to perform the experimental tasks
  • Inability to follow or non-compliance with the procedures of the study
  • for NIBS or MRI:

    • Electronic or ferromagnetic medical implants/device, non-MRI compatible metal implant
    • History of seizures
    • Medication that significantly interacts with NIBS being benzodiazepines, tricyclic antidepressants and antipsychotics
  • Regular use of narcotic drugs
  • Pregnancy
  • Request of not being informed in case of incidental findings
  • Concomitant participation in another trial involving probing of neuronal plasticity
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
25 participants (estimated)

Study arms

  • Experimental
    Active stimulation

    Patterned stimulation (intermittent theta-burst) generating temporal interference in the hippocampal-entorhinal complex; see Beanato et al. 2024, Sci Adv (DOI: 10.1126/sciadv.ado4103) for details.

    Other: Transcranial electric stimulation

  • Placebo comparator
    Control stimulation

    High-frequency (2kHz) electrical stimulation with no frequency shift, generating no temporal interference.

    Other: Transcranial electric stimulation

Interventions

  • OtherTranscranial electric stimulation

    Transcranial temporal interference stimulation (tTIS) is an innovative non-invasive brain stimulation approach, in which two or more independent stimulation channels deliver high-frequency currents in the kHz range (oscillating at f1 and f1 + Δf). These high-frequency currents are assumed to be too high to effectively modulate neuronal activity. Still, by applying a small shift in frequency, they result in a modulated electric field with the envelope oscillating at the low-frequency Δf (target frequency) where the two currents overlap. The peak of the modulated envelope amplitude can be steered towards specific areas located deep in the brain, by tuning the positions of the electrodes and the current ratio across stimulation channels. Here, the investigators apply tTIS via surface electrodes applying a low-intensity, sub-threshold protocol following the safety guidelines for low-intensity transcranial electric stimulation in humans.

06

What researchers measure

Primary outcomes

  1. Speed in the spatial navigation task

    Participant speed (in seconds) of departure to, and reach of, object location in the virtual reality spatial navigation task.

    Time frame: During intervention (approximate duration of intervention = 40 minutes, administered in a single session)

  2. Accuracy in the spatial navigation task

    Accuracy (error, in virtual meters, between correct and recalled object location) in the virtual reality spatial navigation task.

    Time frame: During intervention (approximate duration of intervention = 40 minutes, administered in a single session)

Secondary outcomes

  1. Brain oscillatory activity

    Resting-state and task-related EEG recordings are collected, and metrics of oscillatory activity are extracted to characterize the neural activity associated to the primary outcome.

    Time frame: Peri-interventional (up to 1 hour; approximate duration of intervention = 40 minutes, administered in a single session)

  2. Brain structure and connectivity

    Structural, diffusion-weighted, and resting-state MRI scans are performed during the baseline session and are used to evaluate inter-individual anatomical factors associated to the primary outcome.

    Time frame: Baseline (before the intervention)

Other outcomes

  1. Age (years)

    Participant age will be recorded to examine its influence on individual responsiveness to the intervention.

    Time frame: Baseline (before the intervention)

  2. Montreal Cognitive Assessment questionnaire score

    Participant score on the Montreal Cognitive Assessment questionnaire will be collected to examine its influence on individual responsiveness to the intervention.

    Time frame: Baseline (before the intervention)

  3. Frontal Assessment Battery questionnaire score

    Participant score in the Frontal Assessment Battery questionnaire will be collected to examine its influence on individual responsiveness to the intervention.

    Time frame: Baseline (before the intervention)

07

Study locations

2 sites
  • EPFL, Campus Biotech
    Geneva, Canton of Geneva 1202, Switzerland
  • EPFL Valais, Clinique Romande de readaptation
    Sion, Valais 1950, Switzerland
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Dec 2025; primary completion for Dec 2027, 24 months later.

Of 445 non-industry interventional studies with no phase under Brain Injuries, Traumatic, half reached primary completion within 41 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 64. This study's planned 24 months is below that.

Counting every sponsor, half of 467 studies reached it within 41 months; a quarter within 22 and three quarters within 64.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 14, 2025
First posted
Dec 9, 2025
StartEst.
Dec 2025
Primary completionEst.
Dec 2027
CompletionEst.
Dec 2027
Last update
Dec 9, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 9, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07271524
Lead sponsor
Friedhelm Hummel
Collaborators
Fondation Bertarelli, The Novartis Foundation, Clinique Romande de Readaptation, University of Guadalajara, Swiss National Science Foundation, Wyss Center for Bio and Neuroengineering, Fondation Akiva, Canton du Valais
Responsible party
Friedhelm Hummel (Professor, Defitech Chair of Clinical Neuroengineering Brain Mind Institute, Ecole Polytechnique Fédérale de Lausanne) — Sponsor-investigator
First posted
Dec 9, 2025
Start date
Dec 2025 (estimated)
Primary completion
Dec 2027 (estimated)
Completion
Dec 2027 (estimated)
Last update
Dec 9, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion